Valeur202020212022202320242025TTMFlux de trésorerie liés aux activités d'investissement-240.78 M-141.68 M-5.42 M-96.16 M-420.07 M-129.29 M-704.01 MFlux de trésorerie liés aux activités de financement257.95 M11.3 M65.19 M253.05 M870.52 M74.01 M741.96 MFlux de trésorerie disponible-95.39 M171.22 M-136.13 M-153.89 M-462.85 M156.89 M-50.87 M
Arrowhead Pharmaceuticals, Inc. - Common Stock
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.